Position in GILD
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,886,789,800
-$65,672,688 QoQ
Shares Held
13,537,991
-14.9% QoQ
Ownership
1.09%
of shares outstanding
% of Portfolio
0.36%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 93.01453960192468.ToString("F0")%
None 6.985460398075313.ToString("F0")%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026WELLINGTON MANAGEMENT GROUP LLP holds $38,477,015,517 across 12 Drug Manufacturers - General names. GILD ranks #5 (4.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
13,427,061 | $12,349,807,890 | |
| 2 | MRK |
Merck & Co., Inc.
|
84,314,971 | $10,142,247,857 | |
| 3 | JNJ |
Johnson & Johnson
|
20,075,375 | $4,907,224,662 | |
| 4 | AZN |
Astrazeneca PLC
|
23,751,085 | $4,684,188,978 | |
| 5 | GILD |
Gilead Sciences, Inc.
This page
|
13,537,991 | $1,886,789,800 | |
| 6 | ABBV |
AbbVie Inc.
|
6,897,816 | $1,500,205,997 | |
| 7 | PFE |
Pfizer Inc
|
49,916,961 | $1,401,668,262 | |
| 8 | GSK |
GSK plc
|
11,717,613 | $646,695,059 |
All Filings in GILD
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,886,789,800 | 13,537,991 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,952,462,488 | 15,907,304 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $2,843,657,274 | 25,618,534 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $4,161,007,640 | 37,530,510 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,065,572,247 | 27,358,967 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $3,293,822,472 | 35,659,007 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $2,900,920,673 | 34,600,676 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,573,576,041 | 22,935,083 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,506,587,831 | 20,567,752 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,509,227,150 | 18,630,134 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $1,219,992,021 | 16,279,584 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,282,560,556 | 16,641,502 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $340,359,199 | 4,102,196 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $257,484,322 | 2,999,235 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $18,229,948 | 295,509 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $20,283,504 | 328,159 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $43,368,474 | 729,495 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $51,270,208 | 706,104 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $20,311,469 | 290,787 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $20,936,054 | 304,038 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $33,378,613 | 516,457 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $43,030,425 | 738,593 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $50,830,601 | 804,409 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $72,957,043 | 948,233 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $161,026,981 | 2,153,919 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||